Catalent Z Score

CTLT -  USA Stock  

USD 102.08  0.06  0.06%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Continue to Catalent Piotroski F Score and Catalent Valuation analysis.

Catalent Z Score 

Catalent Market Capitalization is comparatively stable at the moment as compared to the past year. Catalent reported Market Capitalization of 21.18 Billion in 2021. Working Capital is likely to gain to about 2.1 B in 2022, whereas Capital Expenditure is likely to drop (633.6 M) in 2022. Catalent Consolidated Income is comparatively stable at the moment as compared to the past year. Catalent reported Consolidated Income of 672.75 Million in 2021. Earning Before Interest and Taxes EBIT is likely to gain to about 1 B in 2022, whereas Gross Profit is likely to drop slightly above 1.2 B in 2022.

Catalent Z Score Analysis

Catalent's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Z Score 
Sum Of  
5 Factors 
More About Z Score | All Equity Analysis

Current Catalent Z Score

Most of Catalent's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
1.2 * (
Working Capital
Total Assets )
Second Factor
1.4 * (
Retained Earnings
Total Assets )
Thrid Factor
3.3 * (
Total Assets )
Fouth Factor
0.6 * (
Market Value of Equity
Total Liabilities )
Fifth Factor
0.99 * (
Total Assets )

Catalent Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Catalent is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Catalent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Catalent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Catalent's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

In accordance with the company's disclosures, Catalent has a Z Score of 3.4. This is 49.63% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The z score for all United States stocks is 61.01% higher than that of the company.

Catalent Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.
Catalent is currently under evaluation in z score category among related companies.

Catalent Current Valuation Drivers

We derive many important indicators used in calculating different scores of Catalent from analyzing Catalent's financial statements. These drivers represent accounts that assess Catalent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Catalent's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee7.81 K11.17 K15.83 K33.81 K30.43 K32.84 K
Revenue Per Employee230.22 K204.72 K222 K231.1 K207.99 K200.05 K
Average Assets4.31 B4.9 B6.79 B8.52 B9.79 B10.57 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA453.5 M500 M640 M1.11 B1.28 B1.38 B
Earnings Before Interest Taxes and Depreciation Amortization USD453.5 M500 M640 M1.11 B1.28 B1.38 B
Earnings before Tax152 M160 M260 M715 M822.25 M887.16 M
Average Equity1.05 B1.6 B2.11 B3.54 B4.07 B4.39 B
Enterprise Value7.97 B9.86 B13.94 B20.65 B23.75 B25.63 B
Free Cash Flow199.8 M31 M(26 M)(253 M)(227.7 M)(233.69 M)
Invested Capital4.32 B4.98 B5.59 B6.92 B7.96 B6.67 B
Invested Capital Average4.13 B4.2 B5.31 B6.32 B7.27 B6.2 B
Market Capitalization5.59 B7.9 B11.35 B18.42 B21.18 B22.85 B
Tangible Asset Value2.59 B3.03 B4.42 B5.78 B6.64 B7.17 B
Working Capital663.4 M725.1 M1.4 B1.72 B1.98 B2.14 B

Catalent Fundamentals

About Catalent Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Catalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey. Catalent operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 17300 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Catalent without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Recommendations Now


Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Pair Trading with Catalent

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalent position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalent will appreciate offsetting losses from the drop in the long position's value.

Catalent Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Catalent and Bausch Health Companies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Catalent Piotroski F Score and Catalent Valuation analysis. Note that the Catalent information on this page should be used as a complementary analysis to other Catalent's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Catalent Stock analysis

When running Catalent price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Catalent's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catalent. If investors know Catalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Catalent is measured differently than its book value, which is the value of Catalent that is recorded on the company's balance sheet. Investors also form their own opinion of Catalent's value that differs from its market value or its book value, called intrinsic value, which is Catalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catalent's market value can be influenced by many factors that don't directly affect Catalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catalent's value and its price as these two are different measures arrived at by different means. Investors typically determine Catalent value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.